Keywords: کارسینوم درجا; urinary bladder neoplasms; mycobacterium bovis; administration; intravesical; chemotherapy; adjuvant; risk; AUA; American Urological Association; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CUETO; Club Urologico Espanol de Tratamiento Oncologi
مقالات ISI کارسینوم درجا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کارسینوم درجا; EOC; epithelial ovarian cancer; SEOC; serous EOC; EEOC; endometrioid EOC; OSE; ovarian surface epithelium; GEMM; genetically engineered mouse model; CRE; Cre recombinase; fl; floxed; LSL; loxP-STOP-loxP; CMV; cytomegalovirus; STIC; tubal in situ cancer wi
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Keywords: کارسینوم درجا; BC; bladder cancer; NMIBC; non muscle invasive bladder cancer; MIBC; muscle invasive bladder cancer; EAU; European association of urology; EORTC; European Organisation for Research and Treatment of Cancer.; TUR; trans-urethral resection; BCG; Bacillus of
Enfermedad de Bowen, análisis de 64 casos en Colombia
Keywords: کارسینوم درجا; Enfermedad de Bowen; Carcinoma de células escamosas; Carcinoma in situ; Procedimientos quirúrgicos dermatológicos; Radioterapia; CirugÃa de Mohs; Bowen's disease; Squamous cell carcinoma; Carcinoma in situ; Dermatological surgical procedures; Radiothe
Discordance between Ureteroscopic Biopsy and Final Pathology for Upper Tract Urothelial Carcinoma
Keywords: کارسینوم درجا; carcinoma; transitional cell; biopsy; pathology; surgical; ureteroscopy; neoplasm grading; cHG; clinical HG; CIS; carcinoma in situ; cLG; clinical low grade; HG; high grade; NPV; negative predictive value; pHG; pathological HG; PPV; positive predictive va
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study
Keywords: کارسینوم درجا; bladder neoplasms; neoplasm recurrence; local; carcinoma in situ; cystoscopy; optical imaging; AE; adverse event; BCG; bacillus Calmette-Guérin; BL; blue light; BLC; BL cystoscopy; BLFC; flexible BLC; CIS; carcinoma in situ; HAL; hexaminolevulinate; PDD;
Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme
Keywords: کارسینوم درجا; Invasive bladder cancer; Responsiveness of cancer cells to stroma; Fetal mesenchyme; Micropapillary-like structures; p63 isoforms; BLM; bladder mesenchyme; CIS; carcinoma in situ; EMT; epithelial-mesenchymal transition; H&E; hematoxylin and eosin; MIBC; m
Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system
Keywords: کارسینوم درجا; Pragmatic clinical trial; Human papillomavirus; Self-sampling; Cervical cancer; Screening; ASCCP; American Society for Colposcopy and Cervical Pathology; ACS; American Cancer Society; AE; adverse event; AGS; atypical glandular cells; AIS; adenocarcinoma i
Utilidad clÃnica de las biopsias aleatorias en el diagnóstico y tratamiento del tumor vesical no-músculo invasivo: revisión sistemática y metaanálisis
Keywords: کارسینوم درجا; Biopsias aleatorias de vejiga; Carcinoma in situ; Tumor vesical no-músculo invasivo; Random bladder biopsies; Carcinoma in situ; Non-muscle invasive bladder cancer;
Claudin-4 Expression Is Associated With Disease-Free Survival in Breast Carcinoma-in-Situ: Mean Follow-up of 8.2 Years
Keywords: کارسینوم درجا; Breast carcinoma; Carcinoma in situ; Claudin; Survival; Tissue microarray;
Topical Chemotherapy and the Evolving Role of the Biopsy for Ocular Surface Squamous Neoplasia
Keywords: کارسینوم درجا; Ocular surface squamous neoplasia; OSSN; Carcinoma in situ; Squamous cell carcinoma; Conjunctiva; Biopsy; Anterior segment optical coherence tomography; Antineoplastic agents;
Tumor inhibitory effects of intravesical Ganoderma lucidum instillation in the syngeneic orthotopic MB49/C57 bladder cancer mice model
Keywords: کارسینوم درجا; BCG; Bacille Calmette-Guerin; CIS; Carcinoma in situ; CO2; Carbon dioxide; DNA; Deoxyribonucleic acid; GL; Ganoderma lucidum; GLe; Ethanol extract of Ganoderma lucidum; HUC-PC; Pre-cancerous human uroepithelial cells; LDH; Lactate dehydrogenase; PBS; Phos
Purified Protein Derivative Skin test prior to bacillus Calmette-Guérin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer
Keywords: کارسینوم درجا; urinary bladder neoplasms; BCG vaccine; adjuvants; immunologic; skin tests; adverse effects; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; LUTS; lower urinary tract symptoms; NMIBC; nonmuscle invasive bladder cancer; PFS; progression-free surviv
A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer
Keywords: کارسینوم درجا; Imiquimod; Urinary bladder neoplasms; Carcinoma in situ; Administrations, intravesical drug; Immunotherapy;
Programmed death ligand 1 (PD-L1) expression and tumor microenvironment: Implications for patients with oral precancerous lesions
Keywords: کارسینوم درجا; CIS; carcinoma in situ; H&E; hematoxylin and eosin; PD-1; programmed death 1; PD-L1; programmed death ligand 1; SIN; squamous intraepithelial neoplasia; TAM; tumor-associated macrophage; TIL; tumor-infiltrating lymphocyte; Oral cancer; Oral leukoplakia; P
Chromosome instability in tumor resection margins of primary OSCC is a predictor of local recurrence
Keywords: کارسینوم درجا; OSCC; oral cavity squamous cell carcinoma; FISH; fluorescence in situ hybridization; CI; chromosomal instable neoplasia; CIS; carcinoma in situ; LOH; loss of heterozygosity; MPTC; Maastricht Pathology Tissue Collection Department; CNV; copy number variati
TP53 mutations in p53-negative dysplastic urothelial cells from Belgian AAN patients: New evidence for aristolochic acid-induced molecular pathogenesis and carcinogenesis
Keywords: کارسینوم درجا; AA; aristolochic acid; AAN; aristolochic acid nephropathy; BEN; Balkan endemic nephropathy; Cis; carcinoma in situ; FFPE; formalin-fixed paraffin-embedded; IARC; Internation Agency for Research on Cancer; IHC; immunohistochemistry; UC; urothelial carcinom
Emerging roles of the CXCL12/CXCR4 axis in pancreatic cancer progression and therapy
Keywords: کارسینوم درجا; CAFs; cancer-associated fibroblasts; CIS; carcinoma in situ; CSCs; cancer stem cells; CXCL12; CXC ligand 12; CXCR4; CXC chemokine receptor 4; EMT; epithelial mesenchymal transition; HMGB1; high mobility group box 1; MDSCs; myeloid-derived suppressor cells
A Prospective Study of Total Glans Resurfacing for Localized Penile Cancer to Maximize Oncologic and Functional Outcomes in a Tertiary Referral Network
Keywords: کارسینوم درجا; penile neoplasms; reconstructive surgical procedures; skin transplantation; treatment outcome; surveys and questionnaires; CIS; carcinoma in situ; IIEF; International Index of Erectile Function; TGR; total glans excision;
Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications
Keywords: کارسینوم درجا; bladder neoplasms; neoplasm grading; neoplasm invasiveness; CD274 protein; human; urothelium; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; HGT1; high grade T1 bladder cancer; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; PD-1; programme
Clinicopathological Features and Prognostic Value of Incidental Prostatic Adenocarcinoma in Radical Cystoprostatectomy Specimens: A Systematic Review and Meta-Analysis of 13,140 Patients
Keywords: کارسینوم درجا; bladder neoplasms; prostatic neoplasms; cystectomy; prostatectomy; incidental findings; BC; bladder cancer; BCR; biochemical recurrence; CIS; carcinoma in situ; DRE; digital rectal examination; IPC; incidental PC; LN; lymph node; LVI; lymphovascular invas
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: کارسینوم درجا; bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma
Keywords: کارسینوم درجا; urinary tract; carcinoma; biomarkers; lymphocytes; tumor-infiltrating; programmed cell death 1 receptor; CIS; carcinoma in situ; CSS; cancer specific survival; LVI; lymphovascular invasion; NRI; net reclassification improvement; OCD; organ confined diseas
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
Keywords: کارسینوم درجا; urinary bladder neoplasms; neoplasm recurrence; local; urinalysis; cystoscopy; neoplasm invasiveness; CIS; carcinoma in situ; EAU; European Association of Urology; HG; high grade; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonmuscle inva
Efficacy of bacillus Calmette-Guérin Strains for Treatment of Nonmuscle Invasive Bladder Cancer: A Systematic Review and Network Meta-Analysis
Keywords: کارسینوم درجا; urinary bladder neoplasms; BCG vaccine; immunotherapy; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; FDA; United States Food and Drug Administration; MeSH; Medical Subject Headings; NMIBC; nonmuscle invasive bladder cancer; PRISMA; Preferred Rep
Current modalities in cancer immunotherapy: Immunomodulatory antibodies, CARs and vaccines
Keywords: کارسینوم درجا; AAH; atypical adenomatous hyperplasia; AK; actinic keratosis; AML; acute myelogenous leukemia; AMM; asymptomatic multiple myeloma; APC; antigen presenting cell; B-ALL; B cell acute lymphocytic leukemia; B-CLL; B cell chronic lymphocytic leukemia; BD; Bowe
Modelamiento del proceso clÃnico para manejo de usuarios con cáncer tiroideo diferenciado en el Hospital Base Valdivia, Chile
Keywords: کارسینوم درجا; Manejo de la enfermedad; Atención integral de salud; Neoplasias de la tiroides; Carcinoma in situ; Disease management; Comprehensive health care; Thyroid neoplasms; Neoplasms;
A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non–Small Cell Carcinoma In Situ or Non–Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study
Keywords: کارسینوم درجا; Bronchoscopy; Carcinoma in situ; Photodynamic therapy; Lung cancer
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Keywords: کارسینوم درجا; urinary bladder neoplasms; BCG vaccine; treatment failure; cystectomy; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; HG; high grade; IFN; interferon; IVT; intravesical therapy; LVI; lymphovascular invasi
Critical Analysis of Early Recurrence after Laparoscopic Radical Cystectomy in a Large Cohort by the ESUT
Keywords: کارسینوم درجا; urinary bladder neoplasms; cystectomy; laparoscopy; treatment outcome; recurrence; BMI; body mass index; CIS; carcinoma in situ; EBL; estimated blood loss; ESUT; European Association of Urology Section of Uro-Technology; LN; lymph node; LRC; laparoscopic
Sequential bacillus Calmette-Guérin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes
Keywords: کارسینوم درجا; urinary bladder neoplasms; Mycobacterium bovis; mitomycin; drug delivery systems; treatment outcome; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; EMDA; electromotive drug administration; HR; high risk; MIBC; muscle invasive bladder cancer; MMC;
Optical Coherence Tomography as a Tool for In Vivo Staging and Grading of Upper Urinary Tract Urothelial Carcinoma: A Study of Diagnostic Accuracy
Keywords: کارسینوم درجا; tomography; optical coherence; carcinoma; transitional cell; biopsy; diagnosis; sensitivity and specificity; 3D; 3-dimensional; CIS; carcinoma in situ; NPV; negative predictive value; OCT; optical coherence tomography; PPV; positive predictive value; RNU;
The Effect of Concomitant Carcinoma In Situ on Neoadjuvant Chemotherapy for Urothelial Cell Carcinoma of the Bladder: Inferior Pathological Outcomes but No Effect on Survival
Keywords: کارسینوم درجا; urinary bladder; carcinoma in situ; urothelium; neoadjuvant therapy; drug therapycCIS, concomitant CIS; CIS, carcinoma in situ; CSS, cancer specific survival; MIBC, muscle invasive bladder cancer; MVAC, methotrexate, vincristine, doxorubicin and cisplatin
ReviewPrevention of head and neck squamous cell carcinoma: Removing the “chemo” from “chemoprevention”
Keywords: کارسینوم درجا; Chemoprevention; Head and neck cancer; Premalignant lesions; Oral dysplasia; Carcinoma in situ; Second primary tumor;
Multi-institutional Validation of the Predictive Value of Ki-67 in Patients with High Grade Urothelial Carcinoma of the Upper Urinary Tract
Keywords: کارسینوم درجا; biological markers; Ki-67 antigen; urinary tract; carcinoma; transitional cell; CIS; carcinoma in situ; CSS; cancer specific survival; LND; lymph node dissection; LVI; lymphovascular invasion; NRI; net reclassification improvement; RFS; recurrence-free su
Does Squamous Differentiation Portend Worse Outcomes in Urothelial Bladder Cancer?
Keywords: کارسینوم درجا; urinary bladder neoplasms; carcinoma; transitional cell; cystectomy; outcome assessment (health care); pathology; surgical; CIS; carcinoma in situ; DSS; disease specific survival; LN; lymph node; LVI; lymphovascular invasion; NV; nonvariant; OS; overall s
The role of PTEN tumor suppressor pathway staining in carcinoma in situ of the bladder1
Keywords: کارسینوم درجا; Bladder cancer; PTEN; Carcinoma in situ;
5-Year Outcome of a Randomized Prospective Study Comparing bacillus Calmette-Guérin with Epirubicin and Interferon-α2b in Patients with T1 Bladder Cancer
Keywords: کارسینوم درجا; urinary bladder neoplasms; chemotherapy; adjuvant; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; IFN-α2b; interferon-α2b; RFS; recurrence-free survival; TF; treatment failure; TURB; transurethral resection of bla
Bacillus Calmette-Guérin Failure in Patients with Non–Muscle-invasive Urothelial Carcinoma of the Bladder May Be Due to the Urologist's Failure to Detect Urothelial Carcinoma of the Upper Urinary Tract and Urethra
Keywords: کارسینوم درجا; Bladder neoplasms; Urothelial carcinoma; Carcinoma in situ; Bacillus Calmette-Guérin; Upper urinary tract; Cytology; Follow-up studies
Breast MRI of pure ductal carcinoma in situ: Sensitivity of diagnosis and influence of lesion characteristics
Keywords: کارسینوم درجا; Breast; Magnetic resonance imaging; Carcinoma in situ; Intraductal; Noninfiltrating;
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
Keywords: کارسینوم درجا; urinary bladder neoplasms; administration; intravesical; gemcitabine; neoplasm invasiveness; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; MMC; mitomycin C; RFS; recurrence-free survival; TUR; transurethral resection;
Upper Tract Imaging Surveillance is not Effective in Diagnosing Upper Tract Recurrence in Patients Followed for Nonmuscle Invasive Bladder Cancer
Keywords: کارسینوم درجا; carcinoma; transitional cell; urinary bladder neoplasms; diagnostic imaging; watchful waiting; CIS; carcinoma in situ; CT; computerized tomography; IVP; excretory urography; MSKCC; Memorial Sloan-Kettering Cancer Center; NMIBC; nonmuscle invasive bladder
Air Cystoscopy is Superior to Water Cystoscopy for the Diagnosis of Active Hematuria
Keywords: کارسینوم درجا; urinary bladder; urinary bladder neoplasms; cystoscopy; diagnosis; hematuria; AH; active hematuria; CIS; carcinoma in situ; CT; computerized tomography; NH; no hematuria;
Clinical and radiological features of breast tumors according to history of false-positive results in mammography screening
Keywords: کارسینوم درجا; Breast neoplasms; Mass screening; False positives; Biopsy; Fine-needle; Carcinoma in situ
Detection of Bladder Urothelial Carcinoma Using In Vivo Noncontact, Ultraviolet Excited Autofluorescence Measurements Converted into Simple Color Coded Images: A Feasibility Study
Keywords: کارسینوم درجا; urinary bladder; urothelium; cystoscopy; optical imaging; carcinoma in situ; AM; autofluorescence measurement; CIS; carcinoma in situ; OCT; optical coherence tomography; PDD; photodynamic diagnosis; TURB; transurethral bladder resection; UV; ultraviolet;
Impact of Smoking Status on Bladder Tumor Recurrence After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
Keywords: کارسینوم درجا; urinary bladder; smoking; carcinoma; risk; neoplasm recurrence; local; CIS; carcinoma in situ; CPD; cigarettes per day; RNU; radical nephroureterectomy; UTUC; upper tract urothelial cancer;
Sperm Concentration, Testicular Volume and Age Predict Risk of Carcinoma In Situ in Contralateral Testis of Men with Testicular Germ Cell Cancer
Keywords: کارسینوم درجا; carcinoma in situ; testis; semen analysis; biopsy; testicular germ cell tumorCIS, carcinoma in situ; CTB, contralateral testicular biopsy; TGCT, testicular germ cell tumor; TSC, total sperm count
Intravesical valrubicin in patients with bladder carcinoma in situ and contraindication to or failure after bacillus Calmette-Guérin
Keywords: کارسینوم درجا; valrubicin; Bladder tumor; Non-muscle-invasive bladder cancer; Carcinoma in situ; Intravesical Chemotherapy; bacillus Calmette-Guérin
Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia
Keywords: کارسینوم درجا; Germ cell tumour; Immune cell infiltration; Immune privilege; Immune surveillance; Carcinoma in situ; Testis
Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer
Keywords: کارسینوم درجا; apaziquone; urinary bladder neoplasms; drug therapy; administration; intravesical; AE; adverse event; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; MMC; mitomycin C; NMIBC; nonmuscle invasive bladder cancer; TURBT; transurethral resection of bla